Prednisone and Scleroderma renal crisis - a phase IV clinical study of FDA data

Summary:

Scleroderma renal crisis is reported as a side effect among people who take Prednisone (prednisone), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Tacrolimus, and have Systemic sclerosis (scleroderma).

The phase IV clinical study analyzes which people have Scleroderma renal crisis when taking Prednisone. It is created by eHealthMe based on reports of 628,814 people who have side effects when taking Prednisone from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

What is Scleroderma renal crisis?

Scleroderma renal crisis (malignant hypertension develops and causes acute renal failure was once a common cause of death) is found to be associated with 33 drugs and 72 conditions by eHealthMe. Check the latest studies of Scleroderma renal crisis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 18, 2026

628,814 people reported to have side effects when taking Prednisone.
Among them, 60 people (0.01%) have Scleroderma renal crisis.

Could Prednisone cause Scleroderma renal crisis?

Among these 60 people:

How long have people been on Prednisone when they have Scleroderma renal crisis? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Scleroderma renal crisis when taking Prednisone? *

  • female: 76.36 %
  • male: 23.64 %

What is the age of people who have Scleroderma renal crisis when taking Prednisone? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 27.78 %
  • 40-49: 9.26 %
  • 50-59: 27.78 %
  • 60+: 35.19 %

What are other drugs people take besides Prednisone? *

  1. Tacrolimus: 7 people, 11.67%
  2. Prograf: 3 people, 5.00%
  3. Mycophenolate Mofetil: 3 people, 5.00%
  4. Cellcept: 3 people, 5.00%
  5. Rapamune: 3 people, 5.00%
  6. Xanax: 2 people, 3.33%
  7. Lasix: 2 people, 3.33%
  8. Azathioprine: 2 people, 3.33%
  9. Diflucan: 1 person, 1.67%
  10. Klor-Con: 1 person, 1.67%

What are other side effects people have besides Scleroderma renal crisis? *

  1. Renal Impairment (severely reduced kidney function): 8 people, 13.33%
  2. Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 11.67%
  3. High Blood Pressure: 6 people, 10.00%
  4. Thrombocytopenia (decrease of platelets in blood): 6 people, 10.00%
  5. Cardiogenic Shock (inadequate circulation of blood): 5 people, 8.33%
  6. Endocarditis Staphylococcal (an inflammation of the inner layer of the heart by staphylococcal bacterial infection): 5 people, 8.33%
  7. Drug Ineffective: 5 people, 8.33%
  8. Cardiomyopathy (weakening of the heart muscle): 5 people, 8.33%
  9. Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 5 people, 8.33%
  10. Staphylococcal Infection (an infection with staphylococcus bacteria): 5 people, 8.33%

What are the existing conditions these people have? *

  1. Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 6 people, 10.00%
  2. Thrombotic Thrombocytopenic Purpura (a rare blood disorder characterized by clotting in small blood vessels of the body): 5 people, 8.33%
  3. Retinal Exudates (discharge from retina): 5 people, 8.33%
  4. High Blood Pressure: 5 people, 8.33%
  5. Joint Pain: 5 people, 8.33%
  6. Immunodeficiency Disorders: 4 people, 6.67%
  7. Mixed Connective Tissue Disease (an autoimmune disease, in which the body's defence system attacks itself): 4 people, 6.67%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 5.00%
  9. Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 3.33%
  10. Renal Cell Carcinoma (a kidney cancer): 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and have Scleroderma renal crisis?

- Check whether Scleroderma renal crisis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prednisone:

Scleroderma renal crisis treatments and more:

How severe was Scleroderma renal crisis and when was it recovered:

Expand to all the drugs that have ingredients of prednisone:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scleroderma renal crisis:

Browse all the conditions that are associated with Scleroderma renal crisis:


How the study uses the data?

The study uses data from the FDA. It is based on prednisone (the active ingredients of Prednisone) and Prednisone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: